René Wartner and Ricardo Azuero participate with their founding project TrypCo and are based at the Martin-Luther-University Halle-Wittenberg with their other colleagues. Their focus lies on the manufacturing of innovative biopharmaceutics for cancer therapy.
Andreas Simon, René Wartner, Ricardo J. Azuero, and Marcus Böhme (Source: Michael Deutsch)